Skip to content

Effects of different doses of propranolol with methylphenidate in the treatment of ADHD

Comparison of effectiveness and complications Different doses of propranolol with methylphenidate in children with ADHD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204188317N1
Enrollment
30
Registered
2012-04-16
Start date
2011-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder. Disturbance of activity and attention

Interventions

Intervention 1: The study is performed in two groups. The first group is given Methylphenidate propranolol with the dose of 10-20 10 mg per day and the second group is given Methylphenidate propranol
Treatment - Drugs
The study is performed in two groups. The first group is given Methylphenidate propranolol with the dose of 10-20 10 mg per day and the second group is given Methylphenidate propranolol, with the dos
The second group is given Methylphenidate propranolol with the dose of 10-20 10 mg per day and the second group is given Methylphenidate propranolol, with the dose of 40-20 mg per day. Methylphenidate

Sponsors

Research deputy of Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-Having diagnostic criteria based on the revised text of the fourth statistical detection guide to identify mental disorders and tests Conners (Test for diagnosing hyperactivity disorder and it’s grading), In this study, cases of moderate and severe impairment (score greater than or equal to 20 conners) are studied. 2-Age between 6 to 12 years. 3-Obtaining informed consent from parents. Exclusion criteria: 1-Other psychiatric disorder based on a criteria based DSM IV_TR 2-Mental retardation. 3-Having a history of seizures. 4-Any medical problems, including the use of beta blockers and methylphenidate such as asthma, cardiovascular problems, diabetes, history of allergy to drugs, the tic

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The amount of improvement of ADHD symptoms. Timepoint: Before the intervention,Two weeks after intervention,Four weeks after intervention. Method of measurement: Conners test.

Secondary

MeasureTime frame
Side effects. Timepoint: Before the intervention,Two weeks after intervention,Four weeks after intervention. Method of measurement: Onset of symptoms based on parents day comment.;The time for improving the symptoms of disorder attention deficit- hyperactivity disorder. Timepoint: The starting day reduction of symptoms. Method of measurement: Onset of symptoms based on parents day comment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHojjat Bastami

Ahwaz Jondi Shapur University of Medical Sciences

bastamih@yahoo.com+98 61 1374 3038

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026